These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26122241)

  • 1. THE INFLUENCE AND REGULATORY MECHANISM OF Y-BOX BINDING PROTEIN 1 IN OSTEOSARCOMA AND ITS SIGNIFICANCE.
    Zhou WP; Liu X; Yang Y; Liu YF
    J Biol Regul Homeost Agents; 2015; 29(2):485-91. PubMed ID: 26122241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
    Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
    Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
    Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
    Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
    Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB
    Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
    Oda Y; Sakamoto A; Shinohara N; Ohga T; Uchiumi T; Kohno K; Tsuneyoshi M; Kuwano M; Iwamoto Y
    Clin Cancer Res; 1998 Sep; 4(9):2273-7. PubMed ID: 9748149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance and malignancy in human osteosarcoma.
    Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
    Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
    Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
    J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma.
    Fujiwara-Okada Y; Matsumoto Y; Fukushi J; Setsu N; Matsuura S; Kamura S; Fujiwara T; Iida K; Hatano M; Nabeshima A; Yamada H; Ono M; Oda Y; Iwamoto Y
    Br J Cancer; 2013 Mar; 108(4):836-47. PubMed ID: 23462806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells.
    Fujiwara T; Katsuda T; Hagiwara K; Kosaka N; Yoshioka Y; Takahashi RU; Takeshita F; Kubota D; Kondo T; Ichikawa H; Yoshida A; Kobayashi E; Kawai A; Ozaki T; Ochiya T
    Stem Cells; 2014 Apr; 32(4):959-73. PubMed ID: 24715690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44.
    Zhao H; Ma B; Wang Y; Han T; Zheng L; Sun C; Liu T; Zhang Y; Qiu X; Fan Q
    Oncol Rep; 2013 Mar; 29(3):1027-36. PubMed ID: 23314380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
    Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
    Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
    Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
    J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
    Chen Y; Wang CM; Shi YQ; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression.
    Ye Z; Jingzhong L; Yangbo L; Lei C; Jiandong Y
    Oncol Res; 2013; 21(4):201-7. PubMed ID: 24762226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma.
    Fuchs B; Mahlum E; Halder C; Maran A; Yaszemski M; Bode B; Bolander M; Sarkar G
    Gene; 2007 Sep; 399(2):137-43. PubMed ID: 17560052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
    Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.